Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer (NCT06148298)
Cell-free Chromatin Immunoprecipitation (CfChIP) from Blood Plasma As a Diagnostic and Prognostic Tool in Pancreatic Ductal Adenocarcinoma
🩺 Plain-English Summary (8th-Grade Level)
The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples. This is a Non-Human Subject Research study. All participants are de-identified.
Who can join: Review the eligibility criteria below.
Location: University of Central Florida — Orlando, Florida
Age range: 18 Years
🧪 Interventions in This Study
- Non-Human Subject Research study. (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Central Florida — Orlando, Florida
📞 Contact the Study Coordinator
Phone: (407) 266-8742
Email: amoy.fraser@ucf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cancer of Pancreas
- Wet Heparinized Suction for Abdominal Cancer — Tampa, Florida
Explore by condition: All Cancer of Pancreas clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.